diabetes mellitustype 1 diabetestype 2 diabetesgestational diabetesinsulin

Diabetes: Types, Symptoms, and Management Strategies

Diabetes: Types, Symptoms, and Management Strategies Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia—persistently high levels of glucose (sugar) in the bl...

Diabetes: Types, Symptoms, and Management Strategies

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia—persistently high levels of glucose (sugar) in the blood. This condition arises when the body either cannot produce enough insulin or cannot effectively use the insulin it produces. Insulin is a hormone secreted by the pancreas that allows cells to absorb glucose for energy.

While some individuals may experience remission, diabetes is often a lifelong condition that requires careful management to prevent severe long-term health complications. It falls under the medical specialty of endocrinology.

Overview of the most significant symptoms of diabetes
Overview of the most significant symptoms of diabetes

Key Facts

Rates of diabetes worldwide in 2014. The worldwide prevalence was 9.2%.
Rates of diabetes worldwide in 2014. The worldwide prevalence was 9.2%.
  • Global Impact: Approximately 828 million people live with diabetes worldwide.
  • Primary Symptoms: Frequent urination, increased thirst, and increased hunger.
  • Core Cause: Insulin insufficiency or gradual resistance to insulin.
  • Diagnosis: Confirmed via high blood sugar levels and increased HbA1c (average blood sugar over 2-3 months).
  • Treatment: Managed through lifestyle changes, antihyperglycemic medications, and insulin therapy.

Types of Diabetes

Mortality rate of diabetes worldwide in 2012 per million inhabitants: 28–91 92–114 115–141 142–163 164–184 185–209 210–247 248–309 310–404 405–1879
Mortality rate of diabetes worldwide in 2012 per million inhabitants: 28–91 92–114 115–141 142–163 164–184 185–209 210–247 248–309 310–404 405–1879

The World Health Organization classifies diabetes into six categories, though the most common are Type 1, Type 2, and gestational diabetes.

Type 1 Diabetes

Type 1 diabetes is an autoimmune condition where the immune system attacks the insulin-producing beta cells in the pancreas. It typically has a sudden onset and can occur at any age, though the average age of diagnosis is 24. Patients with Type 1 are usually thin or of normal weight and have low or absent endogenous insulin.

Autoimmune attack in type 1 diabetes
Autoimmune attack in type 1 diabetes

Type 2 Diabetes

Type 2 diabetes is characterized by a gradual, insidious onset. It occurs when the body becomes resistant to insulin or the pancreas cannot produce enough to overcome this resistance. It is most common in adults and is frequently associated with obesity. Unlike Type 1, endogenous insulin levels may be normal, decreased, or even increased initially.

Reduced insulin secretion or weaker effect of insulin on its receptor leads to high glucose content in the blood.
Reduced insulin secretion or weaker effect of insulin on its receptor leads to high glucose content in the blood.

Gestational Diabetes

This form of hyperglycemia is first detected during pregnancy. While it often resolves after childbirth, it requires monitoring to ensure the health of both the parent and the child.

Other Specific Types

Other forms include maturity-onset diabetes of the young (MODY), mitochondrial DNA mutations, and pancreatogenic diabetes (Type 3c) resulting from exocrine pancreatic defects such as chronic pancreatitis, cystic fibrosis, or pancreatectomy.

Pathophysiology and Risk Factors

The primary mechanism of diabetes involves the failure of insulin to regulate blood glucose. In a healthy system, insulin release is triggered by food, specifically absorbable glucose.

Mechanism of insulin release in normal pancreatic beta cells. Insulin production is more or less constant within the beta cells. Its release is triggered by food, chiefly food containing absorbable glucose.
Mechanism of insulin release in normal pancreatic beta cells. Insulin production is more or less constant within the beta cells. Its release is triggered by food, chiefly food containing absorbable glucose.

Blood sugar levels fluctuate throughout the day based on meal composition, with sugar-rich meals producing different responses than starch-rich meals.

The fluctuation of blood sugar (red) and the sugar-lowering hormone insulin (blue) in humans during the course of a day with three meals. One of the effects of a sugar-rich vs a starch-rich meal is highlighted.
The fluctuation of blood sugar (red) and the sugar-lowering hormone insulin (blue) in humans during the course of a day with three meals. One of the effects of a sugar-rich vs a starch-rich meal is highlighted.

Various factors can increase the risk of developing diabetes, including:

  • Genetic Factors: Mutations in the insulin gene, insulin receptor mutations, or defects in beta-cell function.
  • Endocrinopathies: Cushing syndrome, acromegaly (growth hormone excess), hyperthyroidism, and hypothyroidism.
  • Infections: Coxsackievirus B and Cytomegalovirus.
  • Medications: Glucocorticoids, statins, thyroid hormones, and beta-adrenergic agonists.

Diagnosis and Clinical Markers

Medical professionals use specific glucose thresholds to differentiate between normal blood sugar, prediabetes, and diabetes. A diagnosis of diabetes mellitus is typically made if plasma glucose is ≥ 11.1 mmol/L (200 mg/dL) regardless of fasting status, or through specific fasting and HbA1c tests.

Blood Glucose Diagnostic Thresholds
Condition 2-hour Glucose (mmol/L) Fasting Glucose (mmol/L) HbA1c (mmol/mol) HbA1c (DCCT %)
Normal < 7.8 < 6.1 < 42 < 6.0
Impaired Fasting Glycaemia < 7.8 6.1–7.0 42–46 6.0–6.4
Impaired Glucose Tolerance ≥ 7.8 < 7.0 42–46 6.0–6.4
Diabetes Mellitus ≥ 11.1 ≥ 7.0 ≥ 48 ≥ 6.5

Complications and Management

Uncontrolled blood sugar can lead to systemic damage over time. Major long-term complications include retinopathy (eye damage), nephropathy (kidney damage), and neuropathy (nerve damage).

Retinopathy, nephropathy, and neuropathy are potential complications of diabetes
Retinopathy, nephropathy, and neuropathy are potential complications of diabetes

Management focuses on glucose control and the prevention of comorbidities. Strategies include:

  • Lifestyle Modifications: Diet and exercise to improve insulin sensitivity.
  • Pharmacological Treatment: Use of insulin for Type 1 and some Type 2 patients, and antihyperglycemic medications for Type 2.
  • Medical Interventions: Blood pressure lowering medications, aspirin, and in some cases of Type 2 diabetes, bariatric or metabolic surgery.

Frequently Asked Questions

What is the difference between Type 1 and Type 2 diabetes?

Type 1 is an autoimmune disease where the body destroys its own insulin-producing cells, usually appearing suddenly in younger people. Type 2 is characterized by insulin resistance and a gradual onset, more commonly occurring in adults and often linked to obesity.

What is HbA1c and why is it used for diagnosis?

HbA1c is a measure of the average blood glucose levels over the past two to three months. It provides a more stable long-term picture of glucose control than a single finger-prick test.

Can diabetes be cured?

While diabetes is often a lifelong condition, some individuals may achieve remission, particularly in Type 2 diabetes through significant lifestyle changes or surgery. However, management is typically required for the long term.

What are the most common warning signs of diabetes?

The most frequent symptoms include excessive thirst (polydipsia), frequent urination (polyuria), and an increase in hunger (polyphagia).

What are the risks of untreated diabetes?

Untreated diabetes can lead to severe complications, including damage to the eyes, kidneys, and nerves, as well as acute conditions like ketoacidosis, which is more common in Type 1 diabetes.

References

  1. "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. Archived from the original on 5 August 2007.
  2. "Diabetes". www.who.int. Archived from the original on 26 February 2023. Retrieved 1 October 2022.
  3. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (July 2009). "Hyperglycemic crises in adult patients with diabetes". Diabetes Care. 32 (7): 1335–1343. doi:10.2337/dc09-9032. PMC 2699725. PMID 19564476. Archived from the original on 2016-06-25.
  4. Krishnasamy S, Abell TL (July 2018). "Diabetic Gastroparesis: Principles and Current Trends in Management". Diabetes Therapy. 9 (Suppl 1): 1–42. doi:10.1007/s13300-018-0454-9. PMC 6028327. PMID 29934758.
  5. Saedi E, Gheini MR, Faiz F, Arami MA (September 2016). "Diabetes mellitus and cognitive impairments". World Journal of Diabetes. 7 (17): 412–422. doi:10.4239/wjd.v7.i17.412. PMC 5027005. PMID 27660698.